Spandana Sphoorty Financial Limited (SPANDANA)

Monitoring Agency Report for the quarter ended June 30, 2026

Filed: 23 Jul 2026, 18:05 IST Exchange: BSE Category: Regulatory Compliance — Monitoring Agency Report

Monitoring agency report for Q1FY27 on rights issue proceeds utilization - No deviation from objects of the issue - No incremental amount received or utilized in Q1FY27 - AUM declined from ₹11,973 Cr (Mar 2024) to ₹3,940 Cr (Dec 2025), recovered to ₹4,420 Cr (Mar 2026) - Profitability improved with marginal net profit in Q4FY26 after six quarters of losses - Funding impacted by covenant breaches on ₹36 Cr borrowings; waivers obtained - Market price ₹303 on July 9, 2026, above issue price ₹230 - No delay in implementation; issue size ₹400 Cr with ₹199.35 Cr received and utilized

Source: Original filing PDF — view on exchange portal

⚡ You're reading this after the fact — subscribers got it instantly

ISA

Indian Stock Alerts BOT

🚨 SPANDANA — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add SPANDANA to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

More on Spandana Sphoorty Financial Limited

Important. The summary above is generated automatically from Spandana Sphoorty Financial Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.